Jennifer Lovejoy, PhD, is the Director of Translational Science at ISB. Prior to ISB, she held executive roles in two health and wellness companies. She was Chief Translational Science Officer at Arivale, a Scientific Wellness company that united systems biology and behavioral science to bring big data to life. Dr. Lovejoy created and oversaw the Arivale clinical program, which produced industry-leading clinical and engagement outcomes, and she provided leadership in a rapid growth, fast-paced startup environment. Prior to Arivale, she was Senior VP of Clinical and Quality Support at Alere Wellbeing (formerly Free & Clear) where she designed and oversaw operations for weight management and tobacco cessation programs offered to employers and government agencies.
During her academic career, Dr. Lovejoy held the Manship Endowed Professorship in Diabetes at LSU’s Pennington Biomedical Research Center and conducted federally funded clinical research studies related to obesity, nutrition, women’s health, and lifestyle behavior change. She also served as President of the Obesity Society (North America), the leading professional society focused on obesity science, treatment and prevention.
Jennifer earned a bachelor’s degree in Zoology from Duke University and an MS degree and a PhD degree in Biological Psychology from Emory University and completed a post-doctoral fellowship in Endocrinology and Metabolism at Emory University School of Medicine. She has published over 60 peer-reviewed articles on her research and holds an affiliate faculty appointment at the Elson S Floyd College of Medicine at Washington State University.
Clinical trials, behavioral science, clinical application of multi-omic data
PhD, Physiological Psychology, Emory University